Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
Splicing factor gene mutations are the most frequent mutations found in patients with the myeloid malignancy myelodysplastic syndrome (MDS), suggesting that spliceosomal dysfunction plays a major role in disease pathogenesis. The aberrantly spliced target genes and deregulated cellular pathways asso...
Main Authors: | Pellagatti, A, Boultwood, J |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Elsevier
2016
|
פריטים דומים
-
Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
מאת: Armstrong, R, et al.
יצא לאור: (2017) -
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
מאת: Boultwood, J, et al.
יצא לאור: (2014) -
Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
מאת: Pellagatti, A, et al.
יצא לאור: (2017) -
Gene expression profiling in the myelodysplastic syndromes.
מאת: Pellagatti, A, et al.
יצא לאור: (2005) -
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
מאת: Johanna Flach, et al.
יצא לאור: (2020-09-01)